Pipeline

A representative sample of the overall Elucida Oncology™ pipeline is shown below.

Lead Program
Folate Receptor Targeted Topoisomerase 1 CDC For Platinum Resistant Ovarian Cancer

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
CDC for Primary Glioma and Other Brain Cancers

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Other Diagnostic and Therapeutic Applications Available for License
Image-Guided Sentinel Lymph Node Mapping - Head and Neck Melanoma

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase complete

Phase 1

Phase 1 Phase complete

Phase 2

Phase 2 Phase in progress
Image-Guided Sentinel Lymph Node Mapping - Breast Cancer

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase complete

Phase 1

Phase 1 Phase in progress

Phase 2

Phase 2 Phase not started
Intraoperative Tumor Margin Assessment

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Multiplexing: Tumor & Nerve Tissue

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started
Nanoparticle Radiotherapeutic Conjugates

Discovery

Discovery Phase complete

Preclinical

Preclinical Phase in progress

Phase 1

Phase 1 Phase not started

Phase 2

Phase 2 Phase not started

Contact Us Today

To learn more about Elucida Oncology™ and our Target or Clear™ development programs.

Contact Us